Compounding pharmacy Greenwich Rx is recalling injectables sold nationwide because they may be contaminated with high levels of bacterial toxins, according to an Oct. 1 Food and Drug Administration (FDA) notice.
The injectables contain an antioxidant used for liver support and in wellness treatments targeting anti-aging and skin health. They were delivered directly to consumers nationwide.
The products were recalled because they may contain elevated levels of endotoxins, or toxins released by certain bacteria that can cause serious reactions if injected. According to the FDA, injecting the endotoxins can lead to symptoms such as fevers, hypotension, inflammatory reactions, anaphylactic shock and death.
Greenwich Rx has received two reports of adverse
reactions that sent consumers to emergency departments for treatment as of the Oct. 1 notice, which it said was due to the drugs being administered improperly.
Here's what to know about the recall.
Which injectables were recalled?
The affected medication was distributed to patients nationwide between June 26, 2026, and Sept. 21, 2026.
- Greenwich RX Glutathione Injection 200 mg/mL: 10 mL packages
- Lot numbers:
- 0060-062426-1
- 0060-062726-1
- 0060-070926-1
- 0060-071426-1
- 0060-071426-2
- 0060-072026-1
- 0060-072726-1
- 0060-072926-1
- 0060-073126-1
- 0060-080426-1
- Beyond use dates
- 10/02/2026
- 10/05/2026
- 10/17/2026
- 10/22/2026
- 10/22/2026
- 10/28/2026
- 11/04/2026
- 11/06/2026
- 11/08/2026
- 11/12/2026
What to do with recalled medications
Consumers with the recalled injectables should stop using them and discard them immediately.
Greenwich Rx is notifying its distributors and customers by email and is arranging disposal of the recalled products. Consumers with questions can contact the company by phone at 866-552-4916 or email at GreenwichRx7542@sedgwick.com.
Consumers experiencing any potential side effects should contact their health care provider. The FDA said adverse reactions or quality problems can be reported online to its MedWatch Adverse Event Reporting program at www.fda.gov/medwatch/report.htm or by mail by downloading the form at www.fda.gov/MedWatch/getforms.htm.
What are compounding pharmacies? Are they safe?
Compounding pharmacies, or special pharmacies that create customized versions of drugs from raw ingredients, have sparked renewed interest in recent years thanks to the surge of GLP-1s and the peptides industry.
Unlike a commercial pharmacy, which sells mass-produced drugs, a compounding pharmacy can develop specific medications to meet a patient's needs, including by adjusting the dose or removing allergens like dyes. Compounding pharmacies are often used for pediatric and veterinary cases where a medicine needs a different format, such as a lower-concentration liquid for a small animal.
These pharmacies are also sometimes used during drug shortages, as the FDA gives temporary approval for them to produce a drug in bulk to fill the void.
This was the case in 2022, when the FDA gave compounders the go-ahead to begin producing their own versions of GLP-1 medications due to a shortage. Tirzepatide and semaglutide were removed from the official drug shortage list in late 2024 and early 2025, but compounding pharmacies have continued to produce their own versions and sell them to millions, especially via telehealth platforms like Hers.
Compounding pharmacies must use FDA-approved ingredients, but the actual formulations themselves are not evaluated for purity, safety or effectiveness, like mass-produced medications. Compounding pharmacies also aren't routinely FDA-regulated, which has led to contamination issues.
These factors have become increasingly controversial, with pharmaceutical giants like Eli Lilly and Novo Nordisk suing compounders to stop or limit the practice.
To check whether your compounding pharmacy is reputable, go to the Alliance for Pharmacy Compounding website and speak with your doctor.
This article originally appeared on USA TODAY: Injectable drugs sold nationwide recalled. See affected medications
